Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Papillary thyroid cancer
ADR ID BADD_A03283
ADR Hierarchy
05      Endocrine disorders
05.02      Thyroid gland disorders
05.02.05      Thyroid neoplasms
05.02.05.005      Papillary thyroid cancer
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.24      Endocrine neoplasms malignant and unspecified
16.24.03      Thyroid neoplasms malignant
16.24.03.002      Papillary thyroid cancer
Description An ADENOCARCINOMA that originates from follicular cells of the THYROID GLAND and accounts for the majority of THYROID CANCER cases. Cells exhibit enlarged, oval, or elongated morphologies with clear, round, nuclei. Fusions of RET, NTRK1, TPM3, and PCM1 genes are associated with this cancer. [MeSH]
MedDRA Code 10033701
MeSH ID D000077273
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Carcinoma papillary thyroid | Papillary thyroid cancer | Thyroid papillary carcinoma | Warthin-like papillary thyroid carcinoma | Thyroid Cancer, Papillary | Cancer, Papillary Thyroid | Cancers, Papillary Thyroid | Papillary Thyroid Cancer | Papillary Thyroid Cancers | Thyroid Cancers, Papillary | Thyroid Carcinoma, Papillary | Carcinoma, Papillary Thyroid | Carcinomas, Papillary Thyroid | Papillary Thyroid Carcinomas | Thyroid Carcinomas, Papillary | Papillary Carcinoma Of Thyroid | Papillary Thyroid Carcinoma | Familial Nonmedullary Thyroid Cancer | Nonmedullary Thyroid Carcinoma | Carcinoma, Nonmedullary Thyroid | Carcinomas, Nonmedullary Thyroid | Nonmedullary Thyroid Carcinomas | Thyroid Carcinoma, Nonmedullary | Thyroid Carcinomas, Nonmedullary
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00479Cladribine0.000153%
BADD_D00566Dabrafenib0.000168%
BADD_D00680Dimethyl fumarate0.003201%
BADD_D01285Levothyroxine0.000015%
BADD_D01298Liraglutide--
BADD_D01304Lithium cation0.001632%
BADD_D01418Methotrexate--
BADD_D01470Minocycline0.000472%
BADD_D01834Prednisone0.000009%
BADD_D01913Ranitidine--
BADD_D02058Sorafenib0.000672%
BADD_D02105Tacrolimus--
BADD_D02165Teriflunomide0.000723%
BADD_D02392Zoledronic acid--
BADD_D02434Cinacalcet0.000391%
BADD_D02464Fingolimod0.001085%
BADD_D02556Ferrous cation0.001255%
The 1th Page    1    Total 1 Pages